{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:32:10Z","timestamp":1793151130470,"version":"4.5.0"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009500","name":"Bangladesh University of Engineering and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009500","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016172","name":"Jashore University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016172","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational Biology and Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.compbiolchem.2026.109246","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T07:00:07Z","timestamp":1784790007000},"page":"109246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["In silico evaluation of bioactive compounds as dual inhibitors targeting ALK and EGFR for non-small cell lung cancer therapy"],"prefix":"10.1016","volume":"125","author":[{"given":"Asif","family":"Abdullah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Enamul Kabir","family":"Talukder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafis Fuad","family":"Shahir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Tarik","family":"Arafat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiolchem.2026.109246_bib1","first-page":"93","article-title":"\"Chapter Four - Erlotinib","volume":"45","author":"Abdelgalil","year":"2020"},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109246_bib2","article-title":"\"Molecular Dynamics Simulation and Pharmacoinformatic Integrated Analysis of Bioactive Phytochemicals from Azadirachta indica (Neem) to Treat Diabetes Mellitus","volume":"2023","author":"Abdullah","year":"2023","journal-title":"J. Chem."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109246_bib3","doi-asserted-by":"crossref","first-page":"13398","DOI":"10.1038\/s41598-023-40160-2","article-title":"\"Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management","volume":"13","author":"Agu","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiolchem.2026.109246_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2025.1524384","article-title":"\"Chemoinformatics analysis of Mangifera indica leaves extracted phytochemicals as potential EGFR kinase modulators,\" (in English)","volume":"13","author":"Al Mashud","year":"2025","journal-title":"Front. Chem."},{"key":"10.1016\/j.compbiolchem.2026.109246_bib5","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1016\/j.csbj.2025.09.038","article-title":"\"Multifaceted disruption of AMPA receptor signaling by CACNG8 variants: Integrated evidence from human genetics and molecular simulation","volume":"27","author":"Alibrandi","year":"2025","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109246_bib6","doi-asserted-by":"crossref","first-page":"22027","DOI":"10.1038\/s41598-024-72577-8","article-title":"\"Investigating the binding affinity, molecular dynamics, and ADMET properties of curcumin-IONPs as a mucoadhesive bioavailable oral treatment for iron deficiency anemia","volume":"14","author":"Alsedfy","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109246_bib7","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12935-023-02990-y","article-title":"\"Recent advances in non-small cell lung cancer targeted therapy; an update review","volume":"23","author":"Araghi","year":"2023","journal-title":"Cancer Cell. Int."},{"key":"10.1016\/j.compbiolchem.2026.109246_bib8","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.sajb.2022.05.028","article-title":"\"Natural bioactive products as promising therapeutics: A review of natural product-based drug development","volume":"151","author":"Aware","year":"2022","journal-title":"South. Afr. J. Bot."},{"issue":"46","key":"10.1016\/j.compbiolchem.2026.109246_bib9","doi-asserted-by":"crossref","first-page":"43856","DOI":"10.1021\/acsomega.3c05785","article-title":"\"Comparative Atomistic Insights on Apo and ATP-I1171N\/S\/T in Nonsmall-Cell Lung Cancer","volume":"8","author":"Balasundaram","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.compbiolchem.2026.109246_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cellsig.2017.11.006","article-title":"\"Phosphorylation of Mig6 negatively regulates the ubiquitination and degradation of EGFR mutants in lung adenocarcinoma cell lines","volume":"43","author":"Boopathy","year":"2018","journal-title":"Cell. Signal."},{"key":"10.1016\/j.compbiolchem.2026.109246_bib11","series-title":"Thermodynamics - Interaction Studies - Solids, Liquids and Gases","article-title":"\"Thermodynamics of Ligand-Protein Interactions: Implications for Molecular Design","author":"Bronowska","year":"2011"},{"issue":"5","key":"10.1016\/j.compbiolchem.2026.109246_bib12","doi-asserted-by":"crossref","DOI":"10.1063\/5.0213317","article-title":"\"Quantum chemical package Jaguar: A survey of recent developments and unique features","volume":"161","author":"Cao","year":"2024","journal-title":"J. Chem. Phys."},{"issue":"11","key":"10.1016\/j.compbiolchem.2026.109246_bib13","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1158\/1541-7786.MCR-18-0171","article-title":"\"ALK Fusion Partners Impact Response to ALK Inhibition: Differential Effects on Sensitivity, Cellular Phenotypes, and Biochemical Properties","volume":"16","author":"Childress","year":"2018","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109246_bib14","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41467-023-35961-y","article-title":"\"Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer","volume":"14","author":"Chmielecki","year":"2023","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.compbiolchem.2026.109246_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100319","article-title":"\"Beyond epidermal growth factor receptor: MET amplification as a general resistance driver to targeted therapy in oncogene-driven non-small-cell lungxa0;cancer,\"","volume":"6","author":"Coleman","year":"2021","journal-title":"ESMO Open."},{"issue":"8","key":"10.1016\/j.compbiolchem.2026.109246_bib16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41571-022-00639-9","article-title":"\"Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management","volume":"19","author":"Cooper","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"40","key":"10.1016\/j.compbiolchem.2026.109246_bib17","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.1021\/acs.jpca.2c05001","article-title":"\"Electronic and Vibrational Manifold of Tetracyanoethylene\u2013Chloronaphthalene Charge Transfer Complex in Solution: Insights from TD-DFT and Ab Initio Molecular Dynamics","volume":"126","author":"Coppola","year":"2022","journal-title":"J. Phys. Chem. A"},{"issue":"38","key":"10.1016\/j.compbiolchem.2026.109246_bib18","doi-asserted-by":"crossref","first-page":"eady8048","DOI":"10.1126\/sciadv.ady8048","article-title":"\"\u03b1 cells use both PC1\/3 and PC2 to process proglucagon peptides and control insulin secretion","volume":"11","author":"Cui","year":"2025","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109246_bib19","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"\"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.compbiolchem.2026.109246_bib20","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1021\/acs.jmedchem.5b01684","article-title":"\"Role of Molecular Dynamics and Related Methods in Drug Discovery","volume":"59","author":"De Vivo","year":"2016","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.compbiolchem.2026.109246_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2025.100076","article-title":"\"Cracking the EGFR code: Cancer biology, resistance mechanisms, and future therapeutic frontiers","volume":"77","author":"Du","year":"2025","journal-title":"Pharmacol. Rev."},{"issue":"21","key":"10.1016\/j.compbiolchem.2026.109246_bib22","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1021\/jm000292e","article-title":"\"Prediction of Drug Absorption Using Multivariate Statistics","volume":"43","author":"Egan","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2026.109246_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.lddd.2025.100157","article-title":"\"In silico investigation of phytocompounds in Bacopa monnieri and Centella asiatica targeting ALS-associated biomarkers HLA-DRB1 and COLIA2","author":"Eshak","year":"2025","journal-title":"Lett. Drug. Des. & Discov."},{"issue":"2","key":"10.1016\/j.compbiolchem.2026.109246_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0295966","article-title":"\"Mitoxantrone and abacavir: An ALK protein-targeted in silico proposal for the treatment of non-small cell lung cancer","volume":"19","author":"Faya Castillo","year":"2024","journal-title":"PLOS ONE"},{"issue":"3","key":"10.1016\/j.compbiolchem.2026.109246_bib25","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s10593-014-1496-1","article-title":"\"Prediction of the Biological Activity Spectra of Organic Compounds Using the Pass Online Web Resource","volume":"50","author":"Filimonov","year":"2014","journal-title":"Chem. Heterocycl. Compd."},{"key":"10.1016\/j.compbiolchem.2026.109246_bib26","unstructured":"U.S. Food and A. Drug, \"FDA approves ensartinib for ALK-positive locally advanced or metastatic non-small cell lung cancer,\" ed. Silver Spring, MD: U.S. Food and Drug Administration, 2024."},{"issue":"7","key":"10.1016\/j.compbiolchem.2026.109246_bib27","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"\"Glide:\u2009A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy,\"","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.compbiolchem.2026.109246_bib28","doi-asserted-by":"crossref","DOI":"10.1103\/PhysRevE.93.033306","article-title":"\"Coupled Nos\\'e-Hoover equations of motion to implement a fluctuating heat-bath temperature,\"","volume":"93","author":"Fukuda","year":"2016","journal-title":"Phys. Rev. E"},{"issue":"3","key":"10.1016\/j.compbiolchem.2026.109246_bib29","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1021\/acs.jcim.9b00843","article-title":"\"Exploring Ligand Stability in Protein Crystal Structures Using Binding Pose Metadynamics","volume":"60","author":"Fusani","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.compbiolchem.2026.109246_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112692","article-title":"\"EGFR-ErbB2 dual kinase inhibitor lapatinib decreases autoantibody levels and worsens renal disease in Interferon \u03b1-accelerated murine lupus","volume":"140","author":"Gallo","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.compbiolchem.2026.109246_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112290","article-title":"\"hERG toxicity assessment: Useful guidelines for drug design","volume":"195","author":"Garrido","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.compbiolchem.2026.109246_bib32","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"\"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert. Opin. Drug. Discov."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109246_bib33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/cc9800071","article-title":"\"A Knowledge-Based Approach in Designing Combinatorial or Medicinal Chemistry Libraries for Drug Discovery. 1. A Qualitative and Quantitative Characterization of Known Drug Databases","volume":"1","author":"Ghose","year":"1999","journal-title":"J. Comb. Chem."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109246_bib34","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12943-018-0810-4","article-title":"\"The function and therapeutic targeting of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC)","volume":"17","author":"Golding","year":"2018","journal-title":"Mol. Cancer"},{"issue":"15","key":"10.1016\/j.compbiolchem.2026.109246_bib35","doi-asserted-by":"crossref","DOI":"10.1063\/1.3382344","article-title":"\"A consistent and accurate ab initio parametrization of density functional dispersion correction (DFT-D) for the 94 elements H-Pu","volume":"132","author":"Grimme","year":"2010","journal-title":"J. Chem. Phys."},{"issue":"7","key":"10.1016\/j.compbiolchem.2026.109246_bib36","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"\"Glide:\u2009A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening,\"","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109246_bib37","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","article-title":"\"OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins","volume":"12","author":"Harder","year":"2016","journal-title":"J. Chem. Theory Comput."},{"issue":"6","key":"10.1016\/j.compbiolchem.2026.109246_bib38","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1177\/1078155220931926","article-title":"\"Afatinib for the treatment of EGFR mutation-positive NSCLC: A review of clinical findings","volume":"26","author":"Harvey","year":"2020","journal-title":"J. Oncol. Pharm. Pract."},{"issue":"6","key":"10.1016\/j.compbiolchem.2026.109246_bib39","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1177\/1078155220931926","article-title":"\"Afatinib for the treatment of EGFR mutation-positive NSCLC: A review of clinical findings","volume":"26","author":"Harvey","year":"2020","journal-title":"J. Oncol. Pharm. Pract."},{"issue":"6","key":"10.1016\/j.compbiolchem.2026.109246_bib40","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s43018-022-00390-1","article-title":"\"Targeting drug-resistant mutations in ALK","volume":"3","author":"He","year":"2022","journal-title":"Nat. Cancer"},{"issue":"3","key":"10.1016\/j.compbiolchem.2026.109246_bib41","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1039\/D2RA06997K","article-title":"\"Unveiling the inhibitory mechanism of aureusidin targeting xanthine oxidase by multi-spectroscopic methods and molecular simulations","volume":"13","author":"He","year":"2023","journal-title":"RSC Adv."},{"issue":"12","key":"10.1016\/j.compbiolchem.2026.109246_bib42","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/cncr.34757","article-title":"\"Targeted therapy for lung cancer: Beyond EGFR and ALK","volume":"129","author":"Herrera-Ju\u00e1rez","year":"2023","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.compbiolchem.2026.109246_bib43","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.neuron.2018.08.011","article-title":"\"Molecular Dynamics Simulation for All","volume":"99","author":"Hollingsworth","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.compbiolchem.2026.109246_bib44","first-page":"37","article-title":"\"Molecular dynamics simulations: advances and applications","author":"Hospital","year":"2015","journal-title":"Adv. Appl. Bioinforma. Chem."},{"issue":"2","key":"10.1016\/j.compbiolchem.2026.109246_bib45","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s40265-020-01449-y","article-title":"\"Brigatinib: A Review in ALK-Inhibitor Na\u00efve Advanced ALK-Positive NSCLC","volume":"81","author":"Hoy","year":"2021","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109246_bib46","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41392-025-02243-6","article-title":"\"Advances in molecular pathology and therapy of non-small cell lung cancer","volume":"10","author":"Huang","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109246_bib47","doi-asserted-by":"crossref","first-page":"35","DOI":"10.14218\/OnA.2023.00011","article-title":"\"Neurological Involvement in EGFR-mutated Non-small-cell Lung Cancer: A Case Report of Third-generation EGFR-tyrosine Kinase Inhibitor Response","volume":"1","author":"Ianza","year":"2023","journal-title":"Oncol. Adv."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109246_bib48","doi-asserted-by":"crossref","first-page":"17134","DOI":"10.1038\/s41598-025-98092-y","article-title":"\"In silico screening of naturally derived dietary compounds as potential butyrylcholinesterase inhibitors for Alzheimer\u2019s disease treatment","volume":"15","author":"Islam","year":"2025","journal-title":"Sci. Rep."},{"issue":"18","key":"10.1016\/j.compbiolchem.2026.109246_bib49","doi-asserted-by":"crossref","DOI":"10.1063\/5.0193281","article-title":"\"Novel barostat implementation for molecular dynamics","volume":"160","author":"Janek","year":"2024","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.compbiolchem.2026.109246_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2025.102380","article-title":"\"Insight into rifampicin resistance behind discordant mutations in RpoB of Mycobacterium tuberculosis: A molecular dynamics simulations study","volume":"16","author":"Khan","year":"2025","journal-title":"Results Chem."},{"issue":"24","key":"10.1016\/j.compbiolchem.2026.109246_bib51","doi-asserted-by":"crossref","first-page":"6638","DOI":"10.1158\/1078-0432.CCR-21-1034","article-title":"\"FDA Approval Summary: Osimertinib for Adjuvant Treatment of Surgically Resected Non\u2013Small Cell Lung Cancer, a Collaborative Project Orbis Review","volume":"27","author":"Koch","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"24","key":"10.1016\/j.compbiolchem.2026.109246_bib52","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.173688","article-title":"\"MIG6 loss confers resistance to ALK\/ROS1 inhibitors in NSCLC through EGFR activation by low-dose EGF","volume":"8","author":"Kondo","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.compbiolchem.2026.109246_bib53","unstructured":"R. Kurzweil, \"Keynote Speech: Raymond Kurzweil,\" presented at the Proceedings of the 2006 ACM\/IEEE conference on Supercomputing, Tampa, Florida, 2006. [Online]. Available: https:\/\/doi.org\/10.1145\/1188455.1198315."},{"issue":"8","key":"10.1016\/j.compbiolchem.2026.109246_bib54","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00894-025-06431-7","article-title":"\"Density functional theory for nanomaterials: structural and spectroscopic applications\u2014a review","volume":"31","author":"Latif","year":"2025","journal-title":"J. Mol. Model."},{"issue":"3","key":"10.1016\/j.compbiolchem.2026.109246_bib55","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1042\/BJ20100609","article-title":"\"Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domain","volume":"430","author":"Lee","year":"2010","journal-title":"Biochem. J."},{"issue":"39","key":"10.1016\/j.compbiolchem.2026.109246_bib56","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1021\/acs.jpcb.4c04901","article-title":"\"Introductory Tutorials for Simulating Protein Dynamics with GROMACS","volume":"128","author":"Lemkul","year":"2024","journal-title":"J. Phys. Chem. B"},{"issue":"7","key":"10.1016\/j.compbiolchem.2026.109246_bib57","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nmeth.4346","article-title":"\"Principal component analysis","volume":"14","author":"Lever","year":"2017","journal-title":"Nat. Methods"},{"issue":"28","key":"10.1016\/j.compbiolchem.2026.109246_bib58","doi-asserted-by":"crossref","first-page":"6157","DOI":"10.1021\/bi2004558","article-title":"\"Efficient Incorporation of Protein Flexibility and Dynamics into Molecular Docking Simulations","volume":"50","author":"Lill","year":"2011","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.compbiolchem.2026.109246_bib59","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"\"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug. Discov. Today. Technol."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109246_bib60","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109246_bib61","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12943-018-0793-1","article-title":"\"EGFR-TKIs resistance via EGFR-independent signaling pathways","volume":"17","author":"Liu","year":"2018","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109246_bib62","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10822-025-00633-0","article-title":"\"Molecular dynamics simulations reveal mechanistic insights into aptamer-induced structural rearrangements in viral capsid proteins","volume":"39","author":"Low","year":"2025","journal-title":"J. Comput. -Aided Mol. Des."},{"issue":"7","key":"10.1016\/j.compbiolchem.2026.109246_bib63","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12032-024-02414-5","article-title":"\"Multifaceted role of erlotinib in various cancer: nanotechnology intervention, patent landscape, and advancements in clinical trials","volume":"41","author":"Mangla","year":"2024","journal-title":"Med. Oncol."},{"issue":"9","key":"10.1016\/j.compbiolchem.2026.109246_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e29560","article-title":"\"Virtual screening, MMGBSA, and molecular dynamics approaches for identification of natural products from South African biodiversity as potential <em>Onchocerca volvulus<\/em> pi-class glutathione S-transferase inhibitors,\"","volume":"10","author":"Maraf","year":"2024","journal-title":"Heliyon"},{"issue":"18","key":"10.1016\/j.compbiolchem.2026.109246_bib65","doi-asserted-by":"crossref","first-page":"6378","DOI":"10.1021\/jp810292n","article-title":"\"Universal Solvation Model Based on Solute Electron Density and on a Continuum Model of the Solvent Defined by the Bulk Dielectric Constant and Atomic Surface Tensions","volume":"113","author":"Marenich","year":"2009","journal-title":"J. Phys. Chem. B"},{"issue":"5","key":"10.1016\/j.compbiolchem.2026.109246_bib66","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1063\/1.467468","article-title":"\"Constant pressure molecular dynamics algorithms","volume":"101","author":"Martyna","year":"1994","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.compbiolchem.2026.109246_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138330","article-title":"\"In silico anticancer activity of isoxazolidine and isoxazolines derivatives: DFT study, ADMET prediction, and molecular docking","volume":"1308","author":"Mellaoui","year":"2024","journal-title":"J. Mol. Struct."},{"issue":"11","key":"10.1016\/j.compbiolchem.2026.109246_bib68","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4792","article-title":"\"UCSF ChimeraX: Tools for structure building and analysis","volume":"32","author":"Meng","year":"2023","journal-title":"Protein Sci."},{"key":"10.1016\/j.compbiolchem.2026.109246_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.109245","article-title":"\"A review on description dynamics and conformational changes of proteins using combination of principal component analysis and molecular dynamics simulation","volume":"183","author":"Moradi","year":"2024","journal-title":"Comput. Biol. Med."},{"issue":"12","key":"10.1016\/j.compbiolchem.2026.109246_bib70","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1021\/jm015507e","article-title":"\"Simple Selection Criteria for Drug-like Chemical Matter","volume":"44","author":"Muegge","year":"2001","journal-title":"J. Med. Chem."},{"issue":"5-6","key":"10.1016\/j.compbiolchem.2026.109246_bib71","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/10799893.2019.1590411","article-title":"\"Molecular docking and dynamics studies of 4-anilino quinazolines for epidermal growth factor receptor tyrosine kinase to find potent inhibitor","volume":"38","author":"Muthuvel","year":"2018","journal-title":"J. Recept. Signal. Transduct."},{"issue":"3","key":"10.1016\/j.compbiolchem.2026.109246_bib72","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"\"Natural Products as Sources of New Drugs over the Nearly Four Decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J. Nat. Prod."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109246_bib73","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41392-022-01200-x","article-title":"\"Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials","volume":"7","author":"Niu","year":"2022","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.compbiolchem.2026.109246_bib74","article-title":"\"Advances of clinically approved small-molecule drugs for the treatment of non-small cell lung cancer","volume":"261","author":"Niu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.compbiolchem.2026.109246_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/cphc.202200491","article-title":"\"On the Uses of PCA to Characterise Molecular Dynamics Simulations of Biological Macromolecules: Basics and Tips for an Effective Use","volume":"24","author":"Palma","year":"2023","journal-title":"ChemPhysChem"},{"issue":"4","key":"10.1016\/j.compbiolchem.2026.109246_bib76","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s40262-015-0242-x","article-title":"\"Oral Bioavailability: Issues and Solutions via Nanoformulations","volume":"54","author":"Pathak","year":"2015","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.compbiolchem.2026.109246_bib77","article-title":"\"Experimental and computational models to understand protein-ligand, metal-ligand and metal-DNA interactions pertinent to targeted cancer and other therapies","volume":"10","author":"Patil","year":"2024","journal-title":"Eur. J. Med. Chem. Rep."},{"issue":"22","key":"10.1016\/j.compbiolchem.2026.109246_bib78","doi-asserted-by":"crossref","first-page":"5715","DOI":"10.1021\/acs.jcim.2c00995","article-title":"\"Qualitative Estimation of Protein\u2013Ligand Complex Stability through Thermal Titration Molecular Dynamics Simulations","volume":"62","author":"Pavan","year":"2022","journal-title":"J. Chem. Inf. Model."},{"issue":"12","key":"10.1016\/j.compbiolchem.2026.109246_bib79","article-title":"\"Computer-aided drug discovery: From traditional simulation methods to language models and quantum computing","volume":"5","author":"Pei","year":"2024","journal-title":"Cell. Rep. Phys. Sci."},{"key":"10.1016\/j.compbiolchem.2026.109246_bib80","article-title":"\"Targeting ALK Rearrangements in NSCLC: Current State of the Art,\" (in English)","volume":"12","author":"Peng","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109246_bib81","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12943-024-02167-9","article-title":"\"Clinical advances and challenges in targeting FGF\/FGFR signaling in lung cancer","volume":"23","author":"Peng","year":"2024","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.compbiolchem.2026.109246_bib82","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1704795","article-title":"\"Alectinib versus crizotinib in untreated ALK-positive non\u2013small-cell lung cancer","volume":"377","author":"Peters","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.compbiolchem.2026.109246_bib83","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"\"pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2026.109246_bib84","article-title":"\"Targeting the PI3K\/AKT\/mTOR pathway in lung cancer: mechanisms and therapeutic targeting,\" (in English)","volume":"16","author":"Qiang","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"18","key":"10.1016\/j.compbiolchem.2026.109246_bib85","doi-asserted-by":"crossref","first-page":"14703","DOI":"10.1074\/jbc.M111.323220","article-title":"\"Disruption of Proprotein Convertase 1\/3 (PC1\/3) Expression in Mice Causes Innate Immune Defects and Uncontrolled Cytokine Secretion","volume":"287","author":"Refaie","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.compbiolchem.2026.109246_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107133","article-title":"\"High-throughput virtual search of small molecules for controlling the mechanical stability of human CD4","volume":"300","author":"Reifs","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.compbiolchem.2026.109246_bib87","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S2213-2600(20)30171-5","article-title":"\"Targeting MET amplification in EGFR-mutant non-small-cell lung cancer,\"","volume":"8","author":"Rosell","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"9","key":"10.1016\/j.compbiolchem.2026.109246_bib88","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1021\/acs.jmedchem.8b00347","article-title":"\"Impact of Dynamically Exposed Polarity on Permeability and Solubility of Chameleonic Drugs Beyond the Rule of 5","volume":"61","author":"Rossi Sebastiano","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2026.109246_bib89","unstructured":"D. Roy, A.K. Todd, and M.M. John, \"GaussView V ersion 6,\" ed, 2019."},{"issue":"12","key":"10.1016\/j.compbiolchem.2026.109246_bib90","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202153693","article-title":"\"Phase-separated foci of EML4-ALK facilitate signalling and depend upon an active kinase conformation","volume":"22","author":"Sampson","year":"2021","journal-title":"EMBO Rep."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109246_bib91","article-title":"\"Relaxation Estimation of RMSD in Molecular Dynamics Immunosimulations","volume":"2012","author":"Schreiner","year":"2012","journal-title":"Comput. Math. Methods Med."},{"issue":"12","key":"10.1016\/j.compbiolchem.2026.109246_bib92","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"\"Epik: a software program for pKaprediction and protonation state generation for drug-like molecules","volume":"21","author":"Shelley","year":"2007","journal-title":"J. Comput. -Aided Mol. Des."},{"issue":"18","key":"10.1016\/j.compbiolchem.2026.109246_bib93","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s40265-018-1028-x","article-title":"\"Dacomitinib: First Global Approval","volume":"78","author":"Shirley","year":"2018","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109246_bib94","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41698-023-00449-x","article-title":"\"ALK fusions in the pan-cancer setting: another tumor-agnostic target?","volume":"7","author":"Shreenivas","year":"2023","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.compbiolchem.2026.109246_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.imu.2024.101458","article-title":"\"In-silico identification of novel natural drug leads against the Ebola virus VP40 protein: A promising approach for developing new antiviral therapeutics","volume":"45","author":"Siddiquee","year":"2024","journal-title":"Inform. Med. Unlocked"},{"issue":"15","key":"10.1016\/j.compbiolchem.2026.109246_bib96","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1021\/acs.jmedchem.5b00201","article-title":"\"Volume of Distribution in Drug Design","volume":"58","author":"Smith","year":"2015","journal-title":"J. Med. Chem."},{"issue":"29","key":"10.1016\/j.compbiolchem.2026.109246_bib97","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1200\/JCO.24.00581","article-title":"\"Lorlatinib Versus Crizotinib in Patients With Advanced ALK-Positive Non\u2013Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study","volume":"42","author":"Solomon","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.compbiolchem.2026.109246_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.116938","article-title":"\"Synergistic anticancer effects of ginsenoside CK and gefitinib against gefitinib-resistant NSCLC by regulating the balance of angiogenic factors through HIF-1\u03b1\/VEGF","volume":"486","author":"Song","year":"2024","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"48","key":"10.1016\/j.compbiolchem.2026.109246_bib99","doi-asserted-by":"crossref","first-page":"46265","DOI":"10.1074\/jbc.M207135200","article-title":"\"Structure of the Epidermal Growth Factor Receptor Kinase Domain Alone and in Complex with a 4-Anilinoquinazoline Inhibitor *","volume":"277","author":"Stamos","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.compbiolchem.2026.109246_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2024.1407331","article-title":"\"Cheminformatics-based identification of phosphorylated RET tyrosine kinase inhibitors for human cancer,\" (in English)","volume":"12","author":"Talukder","year":"2024","journal-title":"Front. Chem."},{"issue":"5","key":"10.1016\/j.compbiolchem.2026.109246_bib101","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/1878-0261.13342","article-title":"\"PI3K\u03b2 inhibition enhances ALK-inhibitor sensitivity in ALK-rearranged lung cancer","volume":"17","author":"Talwelkar","year":"2023","journal-title":"Mol. Oncol."},{"issue":"7","key":"10.1016\/j.compbiolchem.2026.109246_bib102","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/1062936X.2025.2537248","article-title":"\"Targeting MAO-B selectivity: computational screening, docking, and molecular dynamics insights","volume":"36","author":"Thai","year":"2025","journal-title":"SAR QSAR Environ. Res."},{"issue":"12","key":"10.1016\/j.compbiolchem.2026.109246_bib103","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"\"Molecular Properties That Influence the Oral Bioavailability of Drug Candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2026.109246_bib104","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.csbj.2024.05.024","article-title":"\"Addressing docking pose selection with structure-based deep learning: Recent advances, challenges and opportunities","volume":"23","author":"Vittorio","year":"2024","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.compbiolchem.2026.109246_bib105","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.3389\/fmolb.2017.00087","article-title":"\"Recent Developments and Applications of the MMPBSA Method,\" (in English)","volume":"4","author":"Wang","year":"2018","journal-title":"Front. Mol. Biosci."},{"issue":"16","key":"10.1016\/j.compbiolchem.2026.109246_bib106","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","article-title":"\"End-Point Binding Free Energy Calculation with MM\/PBSA and MM\/GBSA: Strategies and Applications in Drug Design","volume":"119","author":"Wang","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.compbiolchem.2026.109246_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbiomech.2020.110106","article-title":"\"PCA of waveforms and functional PCA: A primer for biomechanics","volume":"116","author":"Warmenhoven","year":"2021","journal-title":"J. Biomech."},{"issue":"6","key":"10.1016\/j.compbiolchem.2026.109246_bib108","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1021\/ar010033z","article-title":"\"Molecular Dynamics Simulations of Biological Reactions","volume":"35","author":"Warshel","year":"2002","journal-title":"Acc. Chem. Res."},{"issue":"5","key":"10.1016\/j.compbiolchem.2026.109246_bib109","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/cancers9050052","article-title":"\"Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways,\"","volume":"9","author":"Wee","year":"2017","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.compbiolchem.2026.109246_bib110","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/s41419-022-05260-3","article-title":"\"Inhibiting ALK-TOPK signaling pathway promotes cell apoptosis of ALK-positive NSCLC","volume":"13","author":"Xiao","year":"2022","journal-title":"Cell. Death & Dis."},{"issue":"2","key":"10.1016\/j.compbiolchem.2026.109246_bib111","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/157340911795677602","article-title":"\"Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery,\"","volume":"7","author":"Xuan-Yu","year":"2011","journal-title":"Curr. Comput. -Aided Drug. Des."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109246_bib112","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.lungcan.2013.09.019","article-title":"\"Dual ALK and EGFR inhibition targets a mechanism of acquired resistance to the tyrosine kinase inhibitor crizotinib in <em>ALK<\/em> rearranged lung cancer,\"","volume":"83","author":"Yamaguchi","year":"2014","journal-title":"Lung Cancer"},{"issue":"11","key":"10.1016\/j.compbiolchem.2026.109246_bib113","doi-asserted-by":"crossref","first-page":"7106","DOI":"10.1021\/acs.jctc.1c00810","article-title":"\"Efficient Exploration of Chemical Space with Docking and Deep Learning","volume":"17","author":"Yang","year":"2021","journal-title":"J. Chem. Theory Comput."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109246_bib114","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13321-022-00639-y","article-title":"\"Predicting the mutation effects of protein\u2013ligand interactions via end-point binding free energy calculations: strategies and analyses","volume":"14","author":"Yu","year":"2022","journal-title":"J. Chemin.-."},{"issue":"5","key":"10.1016\/j.compbiolchem.2026.109246_bib115","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1016\/j.cllc.2016.09.006","article-title":"\"Therapeutic Efficacy Comparison of 5 Major EGFR-TKIs in Advanced EGFR-positive Non\u2013Small-cell Lung Cancer: A Network Meta-analysis Based on Head-to-Head Trials","volume":"18","author":"Zhang","year":"2017","journal-title":"Clin. Lung Cancer"}],"container-title":["Computational Biology and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927126003737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927126003737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:38:03Z","timestamp":1793147883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476927126003737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":115,"alternative-id":["S1476927126003737"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2026.109246","relation":{},"ISSN":["1476-9271"],"issn-type":[{"value":"1476-9271","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico evaluation of bioactive compounds as dual inhibitors targeting ALK and EGFR for non-small cell lung cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Computational Biology and Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2026.109246","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109246"}}